C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2006
11/02/2006	WO2006116498A2 Purified form of tanaproget
11/02/2006	WO2006116355A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/02/2006	WO2006116157A2 Dipeptidyl peptidase-iv inhibitors
11/02/2006	WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	WO2006115193A1 Remedy for xanthoma
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006114706A1 Triazole derivatives as vasopressin antagonists
11/02/2006	WO2006114400A1 Novel oxadiazole derivatives and their medical use
11/02/2006	WO2006114371A1 Novel compounds for treating inflammatory diseases
11/02/2006	WO2006114313A1 Pyrazole compounds as prostaglandin receptors ligands
11/02/2006	WO2006114274A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders
11/02/2006	WO2006114272A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS
11/02/2006	WO2006099060A3 Process for the preparation of opioid modulators
11/02/2006	WO2006091428A3 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088921A3 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088919A3 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088837A3 Heterocyclic substituted piperazines with cxcr3 antagonist activity
11/02/2006	WO2005028624A3 Molecular scaffolds for kinase ligand development
11/02/2006	US20060247435 Novel intermediates for linezolid and related compounds
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247286 Oxazolidinone antibiotics and derivatives thereof
11/02/2006	US20060247283 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247262 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247256 Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/02/2006	US20060247247 Pyrazole-amine compounds useful as kinase inhibitors
11/02/2006	US20060247241 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247239 Melanin concentrating hormone antagonists
11/02/2006	US20060247238 5-Chloro-thiophene-2-carboxylic acid ((3S ,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide; anticoagulant, inhibit coagulation factor Xa
11/02/2006	US20060247236 micronized 5-(4,4-dimethyl-2-oxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1H-pyrrole-2-carbonitrile; progesterone receptor modulator; contraception, hormone replacement therapy, carcinomas, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome; storage stable
11/02/2006	US20060247235 progesterone receptor modulator and is effective in contraception, hormone replacement therapy, and treating carcinomas and adenocarcinomas, dysfunctional bleeding, uterine leiomyomata, endometriosis, and polycystic ovary syndrome
11/02/2006	US20060247232 Heterocyclic compound and antitumor agent containing the same as effective ingredient
11/02/2006	US20060247230 chemokines receptor modulators such as 4-(2-ethyl-6-fluoro-3-{1-[3-(4-fluoro-phenylsulfanyl)-propyl]-piperidin-4-yl}-indol-1-yl)-benzoic acid ethyl ester, used for treating inflammatory diseases such as asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
11/02/2006	US20060247227 Substituted piperidines as histamine h3 receptor ligands
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060247210 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
11/02/2006	EP1717231A1 Substituted azole compounds and thereof preparation and application
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717227A1 Substituted indole compounds, their preparation and use in medicaments
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716827A2 Halogenated resin compositions
11/02/2006	EP1716590A1 Assembly of a semiconductor die attached to substrate with oxazoline derivative bearing an electron donor or acceptor functionality
11/02/2006	EP1716143A1 Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006	EP1716142A2 Oxazole derivatives, preparation and therapeutic use therof
11/02/2006	EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006	EP1716121A1 Polymorph of birb 796, a p38map kinase inhibitor
11/02/2006	EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/02/2006	EP1633352B1 Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain
11/02/2006	EP1578723A4 Process for the preparation of oxazolidinones and method of use thereof
11/02/2006	EP1565186B1 N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1301458A4 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0885883B1 Fused heterocyclic compounds and pharmaceutical applications thereof
11/02/2006	EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006	CA2606471A1 Benzisoxazole piperidine compounds and methods of use thereof
11/02/2006	CA2606410A1 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
11/02/2006	CA2606087A1 Novel oxadiazole derivatives and their medical use
11/02/2006	CA2605603A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	CA2605365A1 Remedy for xanthoma
11/02/2006	CA2604603A1 Novel cyclic amines
11/02/2006	CA2603807A1 Polymorph form ii of tanaproget
11/02/2006	CA2603786A1 Purified form of tanaproget
11/02/2006	CA2599419A1 Dipeptidyl peptidase-iv inhibitors
11/01/2006	CN1856490A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/01/2006	CN1856480A P-38 kinase inhibitors
11/01/2006	CN1856310A 喹唑啉钾通道抑制剂 Quinazoline potassium channel inhibitors
11/01/2006	CN1856249A Pyridyl pyrimidines for use as pesticides
11/01/2006	CN1854136A Oxadiazole derivative containing carbazolyl and its electroluminescent device
11/01/2006	CN1854135A Heteronuclear compound with dicyandiamide connection and its medicinal use
11/01/2006	CN1854134A Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
11/01/2006	CN1854118A Indane acetic acid compound
11/01/2006	CN1853630A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/2006
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129260 Isoindolinone kinase inhibitors
10/31/2006	US7129259 Halogenated biaryl heterocyclic compounds and methods of making and using the same
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129254 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates
10/31/2006	US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006	US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
10/31/2006	CA2406685C Oxadiazole derivatives having anticancer effects
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006	CA2247419C Oxazole derivatives, their production and use
10/31/2006	CA2246126C New piperazine compounds
10/31/2006	CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/26/2006	WO2006113704A2 Subtituted heteroaryl cb1 antagonists
10/26/2006	WO2006112666A1 Pyridine derivatives, methods of their preparations, and pharmaceutical compositions containing the same
10/26/2006	WO2006112549A1 Fused heterocyclic compound
10/26/2006	WO2006112313A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
10/26/2006	WO2006111321A1 Azole derivatives in the form of lipase and phospholipase inhibitors

1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 647